Update in Pediatric Asthma: Selected Issues

Asthma is a complex condition that affects 14% of the world's children and the approach to management includes both pharmacologic as well as non-pharmacologic strategies including attention to complex socioeconomic status phenomena. After an historical consideration of asthma, allergic and immu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Disease-a-month 2020-04, Vol.66 (4), p.100886-100886, Article 100886
Hauptverfasser: Azmeh, Roua, Greydanus, Donald E., Agana, Marisha G., Dickson, Cheryl A., Patel, Dilip R., Ischander, Mariam M., Lloyd, Robert D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100886
container_issue 4
container_start_page 100886
container_title Disease-a-month
container_volume 66
creator Azmeh, Roua
Greydanus, Donald E.
Agana, Marisha G.
Dickson, Cheryl A.
Patel, Dilip R.
Ischander, Mariam M.
Lloyd, Robert D.
description Asthma is a complex condition that affects 14% of the world's children and the approach to management includes both pharmacologic as well as non-pharmacologic strategies including attention to complex socioeconomic status phenomena. After an historical consideration of asthma, allergic and immunologic aspects of asthma in children and adolescents are presented. Concepts of socioeconomic aspects of asthma are considered along with environmental features and complications of asthma disparities. Also reviewed are links of asthma with mental health disorders, sleep disturbances and other comorbidities. A stepwise approach to asthma management is discussed that includes pharmacologic and non-pharmacologic strategies in the pediatric population. The role of immunotherapy and use of various immunomodulators are considered as well.
doi_str_mv 10.1016/j.disamonth.2019.100886
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2299766174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0011502919301270</els_id><sourcerecordid>2299766174</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-1608f18221f9c0aa154e145cbc2cf9a6705131c1aebb9b9729ae8a11fb3cff063</originalsourceid><addsrcrecordid>eNqFkN9LwzAQx4MoOqf_gvZRkM5c2jSNb2P4YzBQ0D2HNL2wjHadSSf435vRuVefjjs-d1_uQ8gt0AlQKB7Wk9oF3XabfjVhFGSc0rIsTsgIOBdpCTI_JSNKAVJOmbwglyGsY8skp-fkIgMuKHA5IvfLba17TNwmecfa6d47k0xDv2r1Y_KBDZoe62Qewg7DFTmzugl4fahjsnx--py9pou3l_lsukhNJqBPoaClhZIxsNJQrYHnCDk3lWHGSl0IyiEDAxqrSlZSMKmx1AC2yoy1tMjG5G64u_XdV8ztVeuCwabRG-x2QTEmpSgKEHlExYAa34Xg0aqtd632Pwqo2ptSa3U0pfam1GAqbt4cQnZVi_Vx709NBKYDgPHVb4deBeNwY6IlH62ounP_hvwCAIJ8tA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2299766174</pqid></control><display><type>article</type><title>Update in Pediatric Asthma: Selected Issues</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Azmeh, Roua ; Greydanus, Donald E. ; Agana, Marisha G. ; Dickson, Cheryl A. ; Patel, Dilip R. ; Ischander, Mariam M. ; Lloyd, Robert D.</creator><creatorcontrib>Azmeh, Roua ; Greydanus, Donald E. ; Agana, Marisha G. ; Dickson, Cheryl A. ; Patel, Dilip R. ; Ischander, Mariam M. ; Lloyd, Robert D.</creatorcontrib><description>Asthma is a complex condition that affects 14% of the world's children and the approach to management includes both pharmacologic as well as non-pharmacologic strategies including attention to complex socioeconomic status phenomena. After an historical consideration of asthma, allergic and immunologic aspects of asthma in children and adolescents are presented. Concepts of socioeconomic aspects of asthma are considered along with environmental features and complications of asthma disparities. Also reviewed are links of asthma with mental health disorders, sleep disturbances and other comorbidities. A stepwise approach to asthma management is discussed that includes pharmacologic and non-pharmacologic strategies in the pediatric population. The role of immunotherapy and use of various immunomodulators are considered as well.</description><identifier>ISSN: 0011-5029</identifier><identifier>EISSN: 1557-8194</identifier><identifier>DOI: 10.1016/j.disamonth.2019.100886</identifier><identifier>PMID: 31570159</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Anti-Asthmatic Agents - therapeutic use ; Asthma ; Asthma - drug therapy ; Asthma - therapy ; Child ; Comorbidity ; Endotypes ; Environmental triggers ; Exercise-induced asthma ; Humans ; Immunologic Factors - therapeutic use ; Immunotherapy ; Inhaled corticosteroids ; Leukotriene modulators/montelukast ; Mepolizumab ; Obesity ; Omalizumab ; Pediatrics ; Poverty ; Short-acting beta-2 agonists (SABA) ; Sleep disturbances ; Socioeconomic Factors ; Socioeconomic status</subject><ispartof>Disease-a-month, 2020-04, Vol.66 (4), p.100886-100886, Article 100886</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-1608f18221f9c0aa154e145cbc2cf9a6705131c1aebb9b9729ae8a11fb3cff063</citedby><cites>FETCH-LOGICAL-c371t-1608f18221f9c0aa154e145cbc2cf9a6705131c1aebb9b9729ae8a11fb3cff063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.disamonth.2019.100886$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31570159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Azmeh, Roua</creatorcontrib><creatorcontrib>Greydanus, Donald E.</creatorcontrib><creatorcontrib>Agana, Marisha G.</creatorcontrib><creatorcontrib>Dickson, Cheryl A.</creatorcontrib><creatorcontrib>Patel, Dilip R.</creatorcontrib><creatorcontrib>Ischander, Mariam M.</creatorcontrib><creatorcontrib>Lloyd, Robert D.</creatorcontrib><title>Update in Pediatric Asthma: Selected Issues</title><title>Disease-a-month</title><addtitle>Dis Mon</addtitle><description>Asthma is a complex condition that affects 14% of the world's children and the approach to management includes both pharmacologic as well as non-pharmacologic strategies including attention to complex socioeconomic status phenomena. After an historical consideration of asthma, allergic and immunologic aspects of asthma in children and adolescents are presented. Concepts of socioeconomic aspects of asthma are considered along with environmental features and complications of asthma disparities. Also reviewed are links of asthma with mental health disorders, sleep disturbances and other comorbidities. A stepwise approach to asthma management is discussed that includes pharmacologic and non-pharmacologic strategies in the pediatric population. The role of immunotherapy and use of various immunomodulators are considered as well.</description><subject>Adolescent</subject><subject>Anti-Asthmatic Agents - therapeutic use</subject><subject>Asthma</subject><subject>Asthma - drug therapy</subject><subject>Asthma - therapy</subject><subject>Child</subject><subject>Comorbidity</subject><subject>Endotypes</subject><subject>Environmental triggers</subject><subject>Exercise-induced asthma</subject><subject>Humans</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Immunotherapy</subject><subject>Inhaled corticosteroids</subject><subject>Leukotriene modulators/montelukast</subject><subject>Mepolizumab</subject><subject>Obesity</subject><subject>Omalizumab</subject><subject>Pediatrics</subject><subject>Poverty</subject><subject>Short-acting beta-2 agonists (SABA)</subject><subject>Sleep disturbances</subject><subject>Socioeconomic Factors</subject><subject>Socioeconomic status</subject><issn>0011-5029</issn><issn>1557-8194</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkN9LwzAQx4MoOqf_gvZRkM5c2jSNb2P4YzBQ0D2HNL2wjHadSSf435vRuVefjjs-d1_uQ8gt0AlQKB7Wk9oF3XabfjVhFGSc0rIsTsgIOBdpCTI_JSNKAVJOmbwglyGsY8skp-fkIgMuKHA5IvfLba17TNwmecfa6d47k0xDv2r1Y_KBDZoe62Qewg7DFTmzugl4fahjsnx--py9pou3l_lsukhNJqBPoaClhZIxsNJQrYHnCDk3lWHGSl0IyiEDAxqrSlZSMKmx1AC2yoy1tMjG5G64u_XdV8ztVeuCwabRG-x2QTEmpSgKEHlExYAa34Xg0aqtd632Pwqo2ptSa3U0pfam1GAqbt4cQnZVi_Vx709NBKYDgPHVb4deBeNwY6IlH62ounP_hvwCAIJ8tA</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Azmeh, Roua</creator><creator>Greydanus, Donald E.</creator><creator>Agana, Marisha G.</creator><creator>Dickson, Cheryl A.</creator><creator>Patel, Dilip R.</creator><creator>Ischander, Mariam M.</creator><creator>Lloyd, Robert D.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202004</creationdate><title>Update in Pediatric Asthma: Selected Issues</title><author>Azmeh, Roua ; Greydanus, Donald E. ; Agana, Marisha G. ; Dickson, Cheryl A. ; Patel, Dilip R. ; Ischander, Mariam M. ; Lloyd, Robert D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-1608f18221f9c0aa154e145cbc2cf9a6705131c1aebb9b9729ae8a11fb3cff063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Anti-Asthmatic Agents - therapeutic use</topic><topic>Asthma</topic><topic>Asthma - drug therapy</topic><topic>Asthma - therapy</topic><topic>Child</topic><topic>Comorbidity</topic><topic>Endotypes</topic><topic>Environmental triggers</topic><topic>Exercise-induced asthma</topic><topic>Humans</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Immunotherapy</topic><topic>Inhaled corticosteroids</topic><topic>Leukotriene modulators/montelukast</topic><topic>Mepolizumab</topic><topic>Obesity</topic><topic>Omalizumab</topic><topic>Pediatrics</topic><topic>Poverty</topic><topic>Short-acting beta-2 agonists (SABA)</topic><topic>Sleep disturbances</topic><topic>Socioeconomic Factors</topic><topic>Socioeconomic status</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Azmeh, Roua</creatorcontrib><creatorcontrib>Greydanus, Donald E.</creatorcontrib><creatorcontrib>Agana, Marisha G.</creatorcontrib><creatorcontrib>Dickson, Cheryl A.</creatorcontrib><creatorcontrib>Patel, Dilip R.</creatorcontrib><creatorcontrib>Ischander, Mariam M.</creatorcontrib><creatorcontrib>Lloyd, Robert D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Disease-a-month</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Azmeh, Roua</au><au>Greydanus, Donald E.</au><au>Agana, Marisha G.</au><au>Dickson, Cheryl A.</au><au>Patel, Dilip R.</au><au>Ischander, Mariam M.</au><au>Lloyd, Robert D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Update in Pediatric Asthma: Selected Issues</atitle><jtitle>Disease-a-month</jtitle><addtitle>Dis Mon</addtitle><date>2020-04</date><risdate>2020</risdate><volume>66</volume><issue>4</issue><spage>100886</spage><epage>100886</epage><pages>100886-100886</pages><artnum>100886</artnum><issn>0011-5029</issn><eissn>1557-8194</eissn><abstract>Asthma is a complex condition that affects 14% of the world's children and the approach to management includes both pharmacologic as well as non-pharmacologic strategies including attention to complex socioeconomic status phenomena. After an historical consideration of asthma, allergic and immunologic aspects of asthma in children and adolescents are presented. Concepts of socioeconomic aspects of asthma are considered along with environmental features and complications of asthma disparities. Also reviewed are links of asthma with mental health disorders, sleep disturbances and other comorbidities. A stepwise approach to asthma management is discussed that includes pharmacologic and non-pharmacologic strategies in the pediatric population. The role of immunotherapy and use of various immunomodulators are considered as well.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31570159</pmid><doi>10.1016/j.disamonth.2019.100886</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0011-5029
ispartof Disease-a-month, 2020-04, Vol.66 (4), p.100886-100886, Article 100886
issn 0011-5029
1557-8194
language eng
recordid cdi_proquest_miscellaneous_2299766174
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adolescent
Anti-Asthmatic Agents - therapeutic use
Asthma
Asthma - drug therapy
Asthma - therapy
Child
Comorbidity
Endotypes
Environmental triggers
Exercise-induced asthma
Humans
Immunologic Factors - therapeutic use
Immunotherapy
Inhaled corticosteroids
Leukotriene modulators/montelukast
Mepolizumab
Obesity
Omalizumab
Pediatrics
Poverty
Short-acting beta-2 agonists (SABA)
Sleep disturbances
Socioeconomic Factors
Socioeconomic status
title Update in Pediatric Asthma: Selected Issues
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A58%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Update%20in%20Pediatric%20Asthma:%20Selected%20Issues&rft.jtitle=Disease-a-month&rft.au=Azmeh,%20Roua&rft.date=2020-04&rft.volume=66&rft.issue=4&rft.spage=100886&rft.epage=100886&rft.pages=100886-100886&rft.artnum=100886&rft.issn=0011-5029&rft.eissn=1557-8194&rft_id=info:doi/10.1016/j.disamonth.2019.100886&rft_dat=%3Cproquest_cross%3E2299766174%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2299766174&rft_id=info:pmid/31570159&rft_els_id=S0011502919301270&rfr_iscdi=true